Inc. today provided full-year Abecma® (idecabtagene vicleucel; ide-cel) sales results for 2024, in partnership with Bristol Myers Squibb (BMS). "We are pleased to see Abecma expansion in the third ...
Lipocine Inc. , a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced receipt of revised regulatory ...
When chlorine (as a gas or dissolved in water) is added to sodium bromide solution, the chlorine takes the place of the bromine. Because chlorine is more reactive than bromine, it displaces ...